/Investor DB

AbbVie — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Leal Therapeuticslealtx.comSeries A · Oct 2024 · $45M

Leal Therapeutics is a company focused on CNS (central nervous system) disorders, drawing on academic and drug-development experience in neurology and neurodegenerative disease.

BiotechHealthtechMedical DevicesWorcester, US

Asa Abeliovich(CEO & Founder, Director)

Co-investorsOrbiMedSV Health InvestorsDementia Discovery FundNewpath Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.